The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
CHIMIA
(Sep 2022)
A Challenge: Controlling the Quality of Cell and Gene Therapies
Christoph Meyer,
Alexander Sandoval,
Allyson Decker,
Sophia Nguyen,
Susan Barr,
Andreas Wirth
Affiliations
Christoph Meyer
Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Alexander Sandoval
Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Allyson Decker
Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Sophia Nguyen
Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Susan Barr
Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Andreas Wirth
Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
DOI
https://doi.org/10.2533/chimia.2022.794
Journal volume & issue
Vol. 76, no. 9
Abstract
Read online
No abstracts available.
Keywords
Cell and gene therapies
Good manufacturing practice
Quality control
WeChat QR code
Close
